Michael F. Marusich

2.5k total citations
44 papers, 2.1k citations indexed

About

Michael F. Marusich is a scholar working on Molecular Biology, Clinical Biochemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Michael F. Marusich has authored 44 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 9 papers in Clinical Biochemistry and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Michael F. Marusich's work include Mitochondrial Function and Pathology (24 papers), Metabolism and Genetic Disorders (9 papers) and ATP Synthase and ATPases Research (8 papers). Michael F. Marusich is often cited by papers focused on Mitochondrial Function and Pathology (24 papers), Metabolism and Genetic Disorders (9 papers) and ATP Synthase and ATPases Research (8 papers). Michael F. Marusich collaborates with scholars based in United States, United Kingdom and Netherlands. Michael F. Marusich's co-authors include Roderick Capaldi, James A. Weston, Paul D. Henion, Henry Furneaux, Jan‐Willem Taanman, James Murray, Jing Xie, Julian P. Whitelegge, Puneet Souda and K. Seraydarian and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Advanced Drug Delivery Reviews.

In The Last Decade

Michael F. Marusich

44 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael F. Marusich United States 25 1.6k 403 312 257 210 44 2.1k
Valery I. Shestopalov United States 32 2.2k 1.4× 477 1.2× 89 0.3× 154 0.6× 107 0.5× 78 3.5k
José M. Medina Spain 28 1.4k 0.9× 413 1.0× 95 0.3× 99 0.4× 94 0.4× 73 2.0k
Philip W. Sheard New Zealand 29 1.2k 0.7× 370 0.9× 110 0.4× 173 0.7× 141 0.7× 67 2.4k
B. Gerstl United States 15 1.1k 0.7× 336 0.8× 148 0.5× 199 0.8× 271 1.3× 46 2.0k
Péter L. Nagy United States 26 1.5k 1.0× 241 0.6× 97 0.3× 249 1.0× 39 0.2× 58 2.3k
Gregory C. Kujoth United States 18 2.7k 1.7× 323 0.8× 678 2.2× 152 0.6× 47 0.2× 36 3.7k
Bruce A. Hamilton United States 29 2.0k 1.3× 622 1.5× 84 0.3× 434 1.7× 110 0.5× 69 3.5k
Sergio M. Gloor Switzerland 26 1.4k 0.9× 462 1.1× 34 0.1× 273 1.1× 138 0.7× 43 2.5k
Adam I. Fogel United States 13 2.4k 1.5× 493 1.2× 201 0.6× 749 2.9× 84 0.4× 15 4.2k
Jan‐Olof Karlsson Sweden 22 1.0k 0.6× 513 1.3× 48 0.2× 758 2.9× 142 0.7× 44 2.3k

Countries citing papers authored by Michael F. Marusich

Since Specialization
Citations

This map shows the geographic impact of Michael F. Marusich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael F. Marusich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael F. Marusich more than expected).

Fields of papers citing papers by Michael F. Marusich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael F. Marusich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael F. Marusich. The network helps show where Michael F. Marusich may publish in the future.

Co-authorship network of co-authors of Michael F. Marusich

This figure shows the co-authorship network connecting the top 25 collaborators of Michael F. Marusich. A scholar is included among the top collaborators of Michael F. Marusich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael F. Marusich. Michael F. Marusich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Itagaki, Kiyoshi, Elżbieta Kaczmarek, Woon Yong Kwon, et al.. (2019). Formyl Peptide Receptor-1 Blockade Prevents Receptor Regulation by Mitochondrial Danger-Associated Molecular Patterns and Preserves Neutrophil Function After Trauma. Critical Care Medicine. 48(2). e123–e132. 26 indexed citations
2.
Marusich, Michael F., James Murray, Jing Xie, & Roderick Capaldi. (2009). Novel antibody-based strategies for the rapid diagnosis of mitochondrial disease and dysfunction. The International Journal of Biochemistry & Cell Biology. 41(10). 2081–2088. 6 indexed citations
3.
Nadanaciva, Sashi, John H. Willis, Melissa Barker‐Haliski, et al.. (2009). Lateral-flow immunoassay for detecting drug-induced inhibition of mitochondrial DNA replication and mtDNA-encoded protein synthesis. Journal of Immunological Methods. 343(1). 1–12. 14 indexed citations
4.
Shikuma, Cecilia M., Mariana Gerschenson, Dominic C. Chow, et al.. (2008). Mitochondrial Oxidative Phosphorylation Protein Levels in Peripheral Blood Mononuclear Cells Correlate with Levels in Subcutaneous Adipose Tissue within Samples Differing by HIV and Lipoatrophy Status. AIDS Research and Human Retroviruses. 24(10). 1255–1262. 23 indexed citations
5.
Willis, John H., Roderick Capaldi, Merei Huigsloot, et al.. (2008). Isolated deficiencies of OXPHOS complexes I and IV are identified accurately and quickly by simple enzyme activity immunocapture assays. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1787(5). 533–538. 33 indexed citations
6.
Willis, John H., Grazia Isaya, Oleksandr Gakh, Roderick Capaldi, & Michael F. Marusich. (2008). Lateral-flow immunoassay for the frataxin protein in Friedreich’s ataxia patients and carriers. Molecular Genetics and Metabolism. 94(4). 491–497. 49 indexed citations
7.
Murray, James, et al.. (2008). Monitoring oxidative and nitrative modification of cellular proteins; a paradigm for identifying key disease related markers of oxidative stress. Advanced Drug Delivery Reviews. 60(13-14). 1497–1503. 27 indexed citations
8.
Murray, James, Birgit Schilling, Richard H. Row, et al.. (2007). Small‐scale immunopurification of cytochrome c oxidase for a high‐throughput multiplexing analysis of enzyme activity and amount. Biotechnology and Applied Biochemistry. 48(4). 167–178. 11 indexed citations
9.
Xie, Jing, Michael F. Marusich, Puneet Souda, Julian P. Whitelegge, & Roderick Capaldi. (2007). The mitochondrial inner membrane protein Mitofilin exists as a complex with SAM50, metaxins 1 and 2, coiled‐coil‐helix coiled‐coil‐helix domain‐containing protein 3 and 6 and DnaJC11. FEBS Letters. 581(18). 3545–3549. 169 indexed citations
10.
Murray, James, et al.. (2004). Focused proteomics: towards a high throughput monoclonal antibody-based resolution of proteins for diagnosis of mitochondrial diseases. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1659(2-3). 206–211. 11 indexed citations
11.
Murray, James, Michael F. Marusich, Roderick Capaldi, & Robert Aggeler. (2004). Focused proteomics: Monoclonal antibody‐based isolation of the oxidative phosphorylation machinery and detection of phosphoproteins using a fluorescent phosphoprotein gel stain. Electrophoresis. 25(15). 2520–2525. 40 indexed citations
12.
Murray, James, Bing Zhang, Steven W. Taylor, et al.. (2003). The Subunit Composition of the Human NADH Dehydrogenase Obtained by Rapid One-step Immunopurification. Journal of Biological Chemistry. 278(16). 13619–13622. 91 indexed citations
13.
Triepels, Ralf, Bonnie J. Hanson, Lambert P. van den Heuvel, et al.. (2001). Human Complex I Defects Can Be Resolved by Monoclonal Antibody Analysis into Distinct Subunit Assembly Patterns. Journal of Biological Chemistry. 276(12). 8892–8897. 58 indexed citations
14.
Southworth, Darlene, et al.. (1999). Antibodies to flowering-plant sperm. PROTOPLASMA. 208(1-4). 115–122. 5 indexed citations
15.
Marusich, Michael F., Brian H. Robinson, Jan‐Willem Taanman, et al.. (1997). Expression of mtDNA and nDNA encoded respiratory chain proteins in chemically and genetically-derived Rho0 human fibroblasts: a comparison of subunit proteins in normal fibroblasts treated with ethidium bromide and fibroblasts from a patient with mtDNA depletion syndrome. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1362(2-3). 145–159. 100 indexed citations
16.
Taanman, Jan‐Willem, Miriam D. Burton, Michael F. Marusich, Nancy G. Kennaway, & Roderick Capaldi. (1996). Subunit specific monoclonal antibodies show different steady-state levels of various cytochrome-c oxidase subunits in chronic progressive external ophthalmoplegia. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1315(3). 199–207. 52 indexed citations
17.
Marusich, Michael F., Henry Furneaux, Paul D. Henion, & James A. Weston. (1994). Hu neuronal proteins are expressed in proliferating neurogenic cells. Journal of Neurobiology. 25(2). 143–155. 440 indexed citations
18.
Vogel, Kristine S., Michael F. Marusich, & James A. Weston. (1993). Restriction of neurogenic ability during neural crest cell differentiation. Journal of Neurobiology. 24(2). 162–171. 9 indexed citations
19.
Marusich, Michael F.. (1993). Differentiation of neurogenic precursors within the neural crest cell lineage. Brain Research Bulletin. 30(3-4). 257–263. 4 indexed citations
20.
Marusich, Michael F.. (1988). Efficient hybridoma production using previously frozen splenocytes. Journal of Immunological Methods. 114(1-2). 155–159. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026